More subjects achieved composite reductions of ≥1% HbA1c, ≥5% body weight and ≥5 mmHg SBP with semaglutide vs comparators across the SUSTAIN 1-5 and 7 trials

Kathleen Dungan; V.R. Aroda; Filip Krag Knop; Lawrence A Leiter; Nanna Lausvig; Søren Lindberg; Jakob Ferløv Schwensen; Juris Meier

doi:10.1007/s00125-018-4693-0

More subjects achieved composite reductions of ≥1% HbA1c, ≥5% body weight and ≥5 mmHg SBP with semaglutide vs comparators across the SUSTAIN 1-5 and 7 trials

Kathleen Dungan, V.R. Aroda, Filip Krag Knop, Lawrence A Leiter, Nanna Lausvig, Søren Lindberg, Jakob Ferløv Schwensen, Juris Meier

Steno Diabetes Center Copenhagen

Original language	English
Article number	738
Journal	Diabetologia
Volume	61
Issue number	suppl1
Pages (from-to)	S359-S360
Number of pages	1
ISSN	0012-186X
DOIs	https://doi.org/10.1007/s00125-018-4693-0
Publication status	Published - 1 Oct 2018
Event	54th EASD Annual Meeting: EASD 2018 - Berlin, Germany Duration: 1 Oct 2018 → 5 Oct 2018 https://www.easd.org/programme-2018.html

Conference

Conference	54th EASD Annual Meeting
Country/Territory	Germany
City	Berlin
Period	01/10/2018 → 05/10/2018
Internet address	https://www.easd.org/programme-2018.html

Access to Document

10.1007/s00125-018-4693-0

Cite this

Dungan, K., Aroda, V. R., Knop, F. K., Leiter, L. A., Lausvig, N., Lindberg, S., Ferløv Schwensen, J., & Meier, J. (2018). More subjects achieved composite reductions of ≥1% HbA1c, ≥5% body weight and ≥5 mmHg SBP with semaglutide vs comparators across the SUSTAIN 1-5 and 7 trials. Diabetologia, 61(suppl1), S359-S360. Article 738. https://doi.org/10.1007/s00125-018-4693-0

More subjects achieved composite reductions of ≥1% HbA1c, ≥5% body weight and ≥5 mmHg SBP with semaglutide vs comparators across the SUSTAIN 1-5 and 7 trials. / Dungan, Kathleen; Aroda, V.R.; Knop, Filip Krag et al.
In: Diabetologia, Vol. 61, No. suppl1, 738, 01.10.2018, p. S359-S360.

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

Dungan, K, Aroda, VR, Knop, FK, Leiter, LA, Lausvig, N, Lindberg, S, Ferløv Schwensen, J & Meier, J 2018, 'More subjects achieved composite reductions of ≥1% HbA1c, ≥5% body weight and ≥5 mmHg SBP with semaglutide vs comparators across the SUSTAIN 1-5 and 7 trials', Diabetologia, vol. 61, no. suppl1, 738, pp. S359-S360. https://doi.org/10.1007/s00125-018-4693-0

@article{e7b6cdc4f1094f1ab0a672c9e3ca4530,

title = "More subjects achieved composite reductions of ≥1\% HbA1c, ≥5\% body weight and ≥5 mmHg SBP with semaglutide vs comparators across the SUSTAIN 1-5 and 7 trials",

author = "Kathleen Dungan and V.R. Aroda and Knop, \{Filip Krag\} and Leiter, \{Lawrence A\} and Nanna Lausvig and S{\o}ren Lindberg and \{Ferl{\o}v Schwensen\}, Jakob and Juris Meier",

year = "2018",

month = oct,

day = "1",

doi = "10.1007/s00125-018-4693-0",

language = "English",

volume = "61",

pages = "S359--S360",

journal = "Diabetologia",

issn = "0012-186X",

publisher = "Springer Science and Business Media Deutschland GmbH",

number = "suppl1",

note = "54th EASD Annual Meeting : EASD 2018 ; Conference date: 01-10-2018 Through 05-10-2018",

url = "https://www.easd.org/programme-2018.html",

}

TY - ABST

T1 - More subjects achieved composite reductions of ≥1% HbA1c, ≥5% body weight and ≥5 mmHg SBP with semaglutide vs comparators across the SUSTAIN 1-5 and 7 trials

AU - Dungan, Kathleen

AU - Aroda, V.R.

AU - Knop, Filip Krag

AU - Leiter, Lawrence A

AU - Lausvig, Nanna

AU - Lindberg, Søren

AU - Ferløv Schwensen, Jakob

AU - Meier, Juris

PY - 2018/10/1

Y1 - 2018/10/1

U2 - 10.1007/s00125-018-4693-0

DO - 10.1007/s00125-018-4693-0

M3 - Conference abstract in journal

SN - 0012-186X

VL - 61

SP - S359-S360

JO - Diabetologia

JF - Diabetologia

IS - suppl1

M1 - 738

T2 - 54th EASD Annual Meeting

Y2 - 1 October 2018 through 5 October 2018

ER -